Episode

Glaukos Issued J-Code for Recently Launched Epioxa

Podcast
Eyewire News: The Podcast
Published
Apr 22, 2026
Duration seconds
307
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/BMCL9311807982.mp3
Audio
https://traffic.megaphone.fm/BMCL9311807982.mp3
JSON
/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/glaukos-issued-j-code-for-recently-launched-epioxa
Markdown
/podcast/eyewire-news-the-podcast-7055536/glaukos-issued-j-code-for-recently-launched-epioxa.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/glaukos-issued-j-code-for-recently-launched-epioxa/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/glaukos-issued-j-code-for-recently-launched-epioxa.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting. Learn more about your ad choices. Visit megaphone.fm/adchoices